Table 3.
Demographic and clinical characteristics of retrospective patients
| Characteristics | Patients for discussion (n=480) |
| Demographics | |
| Age, years | 62.0 (55.0–67.5) |
| Male (%) | 363 (75.6) |
| Risk factors | |
| Hypertension | 334 (69.6) |
| Hyperlipidaemia | 429 (89.4) |
| Diabetes | 185 (38.5) |
| Cerebrovascular disease | 102 (21.3) |
| COPD | 7 (1.5) |
| Chronic renal disease | 14 (2.9) |
| Smoker | 226 (47.1) |
| Body mass index, kg/m2 | 25.6 (23.7–27.5) |
| Ccr <60 mL/min/1.73 m2 | 7 (1.5) |
| Cardiovascular characteristics | |
| Previous MI | 49 (10.2) |
| Previous heart failure | 10 (2.1) |
| Peripheral vascular disease | 46 (9.6) |
| Ejection fraction, % | 63.0 (59.0–65.0) |
| Ejection fraction ≤40% | 23 (4.8) |
| CAD symptoms | |
| Silent ischaemia (after medical therapy) | 90 (18.8) |
| Non-ischaemia symptom | 20 (4.2) |
| Stable angina | 370 (77.1) |
| CCS I–II | 325 (87.8) |
| CCS III–IV | 45 (12.2) |
| Number of anti-anginal medications | |
| 0 | 118 (24.6) |
| 1 | 154 (32.1) |
| 2 | 149 (31.0) |
| 3 | 59 (12.3) |
| Extent of coronary disease | |
| 3-vessel disease | 451 (94.0) |
| Left main disease | 129 (26.9) |
| Risk classification | |
| SYNTAX score | 22.5 (16.5–29.5) |
| SYNTAX score tertiles | |
| Low risk (0–22) | 237 (49.4) |
| Intermediate risk (23–32) | 157 (32.7) |
| High risk (≥33) | 86 (17.9) |
| SYNTAX score II recommendation | |
| PCI | 11 (2.3) |
| CABG | 153 (31.9) |
| Equipoise | 316 (65.8) |
| SYNTAX score II 2020 10-year mortality (%) | |
| CABG | 14.8 (9.1–24.7) |
| PCI | 19.4 (11.6–32.2) |
| Euroscore II mortality (%) | 0.80 (0.58–1.06) |
| SinoSCORE II mortality (%) | 0.82 (0.47–1.18) |
| STS score (incidence of postoperative events) | |
| Mortality (%) | 0.49 (0.36–0.70) |
| Mortality or major complications (%) | 5.30 (4.43–6.56) |
| Reoperation (%) | 1.72 (1.46–2.07) |
| Renal failure (%) | 0.43 (0.32–0.61) |
| Stroke (%) | 0.96 (0.73–1.36) |
| Prolonged ventilation (%) | 3.20 (2.62–3.98) |
| DSWI (%) | 0.10 (0.08–0.14) |
| Prolonged hospitalisation (%) | 1.79 (1.33–2.53) |
| Treatment strategy in real world | |
| PCI | 287 (59.8) |
| CABG | 116 (24.2) |
| Medical therapy | 77 (16.0) |
Data presented as median (IQR) and n (%).
CABG, coronary artery bypass graft; CAD, coronary artery disease; Ccr, creatinine clearance rate; CCS, Canadian Cardiovascular Society; COPD, chronic obstructive pulmonary disease; DSWI, deep sternal wound infection; MI, myocardial infarction; PCI, percutaneous coronary intervention; STS, Society of Thoracic Surgeons; SYNTAX, Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery.